Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19462426rdf:typepubmed:Citationlld:pubmed
pubmed-article:19462426lifeskim:mentionsumls-concept:C0010346lld:lifeskim
pubmed-article:19462426lifeskim:mentionsumls-concept:C0666743lld:lifeskim
pubmed-article:19462426lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:19462426pubmed:issue12lld:pubmed
pubmed-article:19462426pubmed:dateCreated2011-3-31lld:pubmed
pubmed-article:19462426pubmed:abstractTextInfliximab is effective maintenance for moderate to severe Crohn's disease (CD); however, problems with immunogenicity and decreased efficacy often complicate long-term use. Durability of infliximab maintenance therapy over multiple years has not been defined.lld:pubmed
pubmed-article:19462426pubmed:languageenglld:pubmed
pubmed-article:19462426pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19462426pubmed:citationSubsetIMlld:pubmed
pubmed-article:19462426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19462426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19462426pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19462426pubmed:statusMEDLINElld:pubmed
pubmed-article:19462426pubmed:monthDeclld:pubmed
pubmed-article:19462426pubmed:issn1536-4844lld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:BinionDavid...lld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:OttersonMary...lld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:JohnsonKathry...lld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:Ananthakrishn...lld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:IssaMazenMlld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:BeaulieuDawn...lld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:SkarosSueSlld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:ZadvornovaYel...lld:pubmed
pubmed-article:19462426pubmed:authorpubmed-author:GonzagaJason...lld:pubmed
pubmed-article:19462426pubmed:copyrightInfoCopyright © 2009 Crohn's & Colitis Foundation of America, Inc.lld:pubmed
pubmed-article:19462426pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19462426pubmed:volume15lld:pubmed
pubmed-article:19462426pubmed:ownerNLMlld:pubmed
pubmed-article:19462426pubmed:authorsCompleteYlld:pubmed
pubmed-article:19462426pubmed:pagination1837-43lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:meshHeadingpubmed-meshheading:19462426...lld:pubmed
pubmed-article:19462426pubmed:year2009lld:pubmed
pubmed-article:19462426pubmed:articleTitleDurability of infliximab in Crohn's disease: a single-center experience.lld:pubmed
pubmed-article:19462426pubmed:affiliationDivision of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.lld:pubmed
pubmed-article:19462426pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19462426pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed